drugset / Trial / NCT06995287
Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Pelvic Pain Suggestive of Dysmenorrhea
Phase 3
Recruiting
222 enrolled
Nantes University Hospital
Merz Pharmaceuticals GmbH · collabMinistry of Health, France · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of the study is to evaluate the global impression of improvement at 3 months following intramyometrial botulinum toxin injections via hysteroscopy in women with severe primary dysmenorrhea who have failed first-line medical treatment, compared to intramyometrial placebo injections.
Timeline
- Start
- 2026-02-09
- Primary completion
- 2028-06-09
- Completion
- 2028-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | Other |